| Olea europaea leaf extract alters microRNA expression in human glioblastoma cells B Tunca, G Tezcan, G Cecener, U Egeli, S Ak, H Malyer, G Tumen, A Bilir Journal of cancer research and clinical oncology 138, 1831-1844, 2012 | 87 | 2012 |
| Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients B Tunca, G Tezcan, G Cecener, U Egeli, A Zorluoglu, T Yilmazlar, S Ak, ... Journal of cancer research and clinical oncology 139, 691-702, 2013 | 81 | 2013 |
| Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer GG Eskiler, G Cecener, G Dikmen, U Egeli, B Tunca European journal of pharmaceutical sciences 120, 73-88, 2018 | 74 | 2018 |
| Triple negative breast cancer: new therapeutic approaches and BRCA status G Guney Eskiler, G Cecener, U Egeli, B Tunca Apmis 126 (5), 371-379, 2018 | 63 | 2018 |
| Ficus carica Latex Prevents Invasion Through Induction of Let-7d Expression in GBM Cell Lines G Tezcan, B Tunca, A Bekar, M Yalcin, S Sahin, F Budak, G Cecener, ... Cellular and molecular neurobiology 35, 175-187, 2015 | 55 | 2015 |
| Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression G Tezcan, B Tunca, A Bekar, F Budak, S Sahin, G Cecener, U Egeli, ... American journal of cancer research 4 (5), 572, 2014 | 55 | 2014 |
| microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells G Tezcan, B Tunca, A Bekar, M Preusser, AS Berghoff, U Egeli, ... Cellular and molecular neurobiology 34, 679-692, 2014 | 52 | 2014 |
| Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions IE Eryilmaz, G Cecener, S Erer, U Egeli, B Tunca, M Zarifoglu, B Elibol, ... Neurological research 39 (11), 965-972, 2017 | 47 | 2017 |
| Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer G Guney Eskiler, G Cecener, U Egeli, B Tunca Pharmaceutical research 35, 1-20, 2018 | 39 | 2018 |
| Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer G Tezcan, B Tunca, S Ak, G Cecener, U Egeli World Journal of Gastrointestinal Oncology 8 (1), 83, 2016 | 37 | 2016 |
| BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients G Cecener, U Egeli, B Tunca, E Erturk, S Ak, S Gokgoz, I Tasdelen, ... Cancer investigation 32 (8), 375-387, 2014 | 36 | 2014 |
| MicroRNA expression patterns of tumors in early-onset colorectal cancer patients S Ak, B Tunca, G Tezcan, G Cecener, U Egeli, T Yilmazlar, E Ozturk, ... journal of surgical research 191 (1), 113-122, 2014 | 36 | 2014 |
| The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites Ü Egeli, L Özkan, B Tunca, S Kahraman, G Çeçener, E Ergül, K Engin Head & neck 22 (6), 591-598, 2000 | 36 | 2000 |
| The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma B Yurdacan, U Egeli, GG Eskiler, IE Eryilmaz, G Cecener, B Tunca Human & experimental toxicology 38 (2), 201-215, 2019 | 35 | 2019 |
| Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives U Egeli, G Cecener, B Tunca, I Tasdelen Cancer investigation 24 (5), 484-491, 2006 | 33 | 2006 |
| The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma G Cecener, B Tunca, U Egeli, A Bekar, G Tezcan, E Erturk, N Bayram, ... Cellular and molecular neurobiology 32, 237-244, 2012 | 31 | 2012 |
| Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro G Tezcan, MO Taskapilioglu, B Tunca, A Bekar, H Demirci, H Kocaeli, ... Biomedicine & Pharmacotherapy 90, 713-723, 2017 | 29 | 2017 |
| BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer E Erturk, G Cecener, G Tezcan, U Egeli, B Tunca, S Gokgoz, S Tolunay, ... Gene 556 (2), 163-169, 2015 | 29 | 2015 |
| Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations E Erturk, G Cecener, U Egeli, B Tunca, G Tezcan, S Gokgoz, S Tolunay, ... Molecular and cellular biochemistry 395, 77-88, 2014 | 29 | 2014 |
| Common fragile site expression and genetic predisposition to breast cancer G Çeçener, Ü Egeli, I Taşdelen, B Tunca, H Duman, A Kizil Teratogenesis, carcinogenesis, and mutagenesis 18 (6), 279-291, 1998 | 29 | 1998 |
